Mortality in first 5 years in infants with functional single ventricle born in Texas, 1996 to 2003

David E Fixler1, Wendy N Nembhard, Jason L Salemi

  • 1Department of Pediatrics, University of Texas Health Science Center, Dallas, USA. david.fixler@childrens.com

Circulation
|January 27, 2010
PubMed

Insights

Five-year survival for infants with functional single ventricle improved significantly between 1996-2003. Key factors influencing survival include defect type, extracardiac anomalies, and race/ethnicity.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease Research
  • Public Health Surveillance

Background:

  • Infants with functional single ventricle face high early mortality risks.
  • Existing survival data often exclude preoperative or pre-transfer deaths.
  • Population-based studies are crucial for comprehensive outcome assessment.

Purpose of the Study:

  • To estimate 5-year survival rates in infants with functional single ventricle.
  • To identify factors impacting survival in this population.
  • To assess improvements in outcomes over time.

Main Methods:

  • Utilized the Texas Birth Defects Registry data from 1996-2003.
  • Linked registry data with state and national vital records for survival analysis.
  • Examined effects of defect type, birth characteristics, and demographics on survival.

Main Results:

  • Five-year survival varied by defect: Hypoplastic Left Heart Syndrome (HLHS) 38.0%, Single Ventricle (SV) 56.1%, Pulmonary Atresia Intact Ventricular Septum (PAIVS) 55.7%, Tricuspid Atresia (TA) 74.6%.
  • Extracardiac anomalies increased death risk by 84%.
  • Racial/ethnic disparities noted: Non-Hispanic Blacks (41% higher risk), Hispanics (26% higher risk) vs. Non-Hispanic Whites. Survival improved in 2001-2003 (47% lower risk) compared to 1996-2000.

Conclusions:

  • Significant improvements in 5-year survival observed, especially for HLHS and SV.
  • Further research is needed to understand racial/ethnic and regional outcome disparities.
  • Population-based data provides critical insights into congenital heart defect survival trends.
Abstract